Stockreport

GoodRx's (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8% [Yahoo! Finance]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF On the other hand, the company's full-year revenue guidance of $765 million at the midpoint came in 6.2% below analysts' estimates. Its non-GAAP profit of $0.09 per shar [Read more]